-
1
-
-
0034020466
-
Acetylation and chromosomal functions
-
Cheung, W. L.; Briggs, S. D.; Allis, C. D. Acetylation and chromosomal functions Curr. Opin. Cell Biol. 2000, 12 (3) 326-333
-
(2000)
Curr. Opin. Cell Biol.
, vol.12
, Issue.3
, pp. 326-333
-
-
Cheung, W.L.1
Briggs, S.D.2
Allis, C.D.3
-
2
-
-
67849103579
-
NO sparks off chromatin: Tales of a multifaceted epigenetic regulator
-
Illi, B.; Colussi, C.; Grasselli, A.; Farsetti, A.; Capogrossi, M. C.; Gaetano, C. NO sparks off chromatin: tales of a multifaceted epigenetic regulator Pharmacol. Ther. 2009, 123 (3) 344-352
-
(2009)
Pharmacol. Ther.
, vol.123
, Issue.3
, pp. 344-352
-
-
Illi, B.1
Colussi, C.2
Grasselli, A.3
Farsetti, A.4
Capogrossi, M.C.5
Gaetano, C.6
-
3
-
-
34248656480
-
Histone deacetylases: An important class of cellular regulators with a variety of functions
-
Hildmann, C.; Riester, D.; Schwienhorst, A. Histone deacetylases: an important class of cellular regulators with a variety of functions Appl. Microbiol. Biotechnol. 2007, 75 (3) 487-497
-
(2007)
Appl. Microbiol. Biotechnol.
, vol.75
, Issue.3
, pp. 487-497
-
-
Hildmann, C.1
Riester, D.2
Schwienhorst, A.3
-
4
-
-
65449166411
-
Novel structural insights into class i and II histone deacetylases
-
Ficner, R. Novel structural insights into class I and II histone deacetylases Curr. Top. Med. Chem. 2009, 9 (3) 235-240
-
(2009)
Curr. Top. Med. Chem.
, vol.9
, Issue.3
, pp. 235-240
-
-
Ficner, R.1
-
5
-
-
77952880971
-
Histone deacetylase inhibitors: Keeping momentum for neuromuscular and cardiovascular diseases treatment
-
Colussi, C.; Illi, B.; Rosati, J.; Spallotta, F.; Farsetti, A.; Grasselli, A.; Mai, A.; Capogrossi, M. C.; Gaetano, C. Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment Pharmacol. Res. 2010, 62 (1) 3-10
-
(2010)
Pharmacol. Res.
, vol.62
, Issue.1
, pp. 3-10
-
-
Colussi, C.1
Illi, B.2
Rosati, J.3
Spallotta, F.4
Farsetti, A.5
Grasselli, A.6
Mai, A.7
Capogrossi, M.C.8
Gaetano, C.9
-
6
-
-
37849010584
-
Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling
-
Illi, B.; Dello Russo, C.; Colussi, C.; Rosati, J.; Pallaoro, M.; Spallotta, F.; Rotili, D.; Valente, S.; Ragone, G.; Martelli, F.; Biglioli, P.; Steinkuhler, C.; Gallinari, P.; Mai, A.; Capogrossi, M. C.; Gaetano, C. Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling Circ. Res. 2008, 102 (1) 51-58
-
(2008)
Circ. Res.
, vol.102
, Issue.1
, pp. 51-58
-
-
Illi, B.1
Dello Russo, C.2
Colussi, C.3
Rosati, J.4
Pallaoro, M.5
Spallotta, F.6
Rotili, D.7
Valente, S.8
Ragone, G.9
Martelli, F.10
Biglioli, P.11
Steinkuhler, C.12
Gallinari, P.13
Mai, A.14
Capogrossi, M.C.15
Gaetano, C.16
-
7
-
-
3943054839
-
The Sir2 family of protein deacetylases
-
Blander, G.; Guarente, L. The Sir2 family of protein deacetylases Annu. Rev. Biochem. 2004, 73, 417-435
-
(2004)
Annu. Rev. Biochem.
, vol.73
, pp. 417-435
-
-
Blander, G.1
Guarente, L.2
-
8
-
-
79961212451
-
Vascular nitric oxide: Formation and function
-
Jin, R. C.; Loscalzo, J. Vascular nitric oxide: formation and function J. Blood Med. 2010, 1, 147-162
-
(2010)
J. Blood Med.
, vol.1
, pp. 147-162
-
-
Jin, R.C.1
Loscalzo, J.2
-
9
-
-
0036196417
-
NO as a signalling molecule in the nervous system
-
Esplugues, J. V. NO as a signalling molecule in the nervous system Br. J. Pharmacol. 2002, 135 (5) 1079-1095
-
(2002)
Br. J. Pharmacol.
, vol.135
, Issue.5
, pp. 1079-1095
-
-
Esplugues, J.V.1
-
10
-
-
0035139227
-
Physiology of nitric oxide in skeletal muscle
-
Stamler, J. S.; Meissner, G. Physiology of nitric oxide in skeletal muscle Physiol. Rev. 2001, 81 (1) 209-237
-
(2001)
Physiol. Rev.
, vol.81
, Issue.1
, pp. 209-237
-
-
Stamler, J.S.1
Meissner, G.2
-
11
-
-
33846360376
-
Targeting nitric oxide for cancer therapy
-
Hirst, D.; Robson, T. Targeting nitric oxide for cancer therapy J. Pharm. Pharmacol. 2007, 59 (1) 3-13
-
(2007)
J. Pharm. Pharmacol.
, vol.59
, Issue.1
, pp. 3-13
-
-
Hirst, D.1
Robson, T.2
-
12
-
-
18844391239
-
Nitric oxide as a regulator of inflammatory processes
-
Wallace, J. L. Nitric oxide as a regulator of inflammatory processes Mem. Inst. Oswaldo Cruz 2005, 100, 5-9
-
(2005)
Mem. Inst. Oswaldo Cruz
, vol.100
, pp. 5-9
-
-
Wallace, J.L.1
-
13
-
-
46749104083
-
Nitric oxide-mediated protein modification in cardiovascular physiology and pathology
-
Goedecke, A.; Schrader, J.; Reinartz, M. Nitric oxide-mediated protein modification in cardiovascular physiology and pathology Proteomics Clin. Appl. 2008, 2 (6) 811-822
-
(2008)
Proteomics Clin. Appl.
, vol.2
, Issue.6
, pp. 811-822
-
-
Goedecke, A.1
Schrader, J.2
Reinartz, M.3
-
14
-
-
79953744099
-
Smad-interacting protein-1 and microRNA 200 family define a nitric oxide-dependent molecular circuitry involved in embryonic stem cell mesendoderm differentiation
-
Rosati, J.; Spallotta, F.; Nanni, S.; Grasselli, A.; Antonini, A.; Vincenti, S.; Presutti, C.; Colussi, C.; D'Angelo, C.; Biroccio, A.; Farsetti, A.; Capogrossi, M. C.; Illi, B.; Gaetano, C. Smad-interacting protein-1 and microRNA 200 family define a nitric oxide-dependent molecular circuitry involved in embryonic stem cell mesendoderm differentiation Arterioscler. Thromb. Vasc. Biol. 2011, 31 (4) 898-907
-
(2011)
Arterioscler. Thromb. Vasc. Biol.
, vol.31
, Issue.4
, pp. 898-907
-
-
Rosati, J.1
Spallotta, F.2
Nanni, S.3
Grasselli, A.4
Antonini, A.5
Vincenti, S.6
Presutti, C.7
Colussi, C.8
D'Angelo, C.9
Biroccio, A.10
Farsetti, A.11
Capogrossi, M.C.12
Illi, B.13
Gaetano, C.14
-
15
-
-
84876580701
-
A nitric oxide-dependent cross-talk between class i and III histone deacetylases accelerates skin repair
-
Spallotta, F.; Cencioni, C.; Straino, S.; Nanni, S.; Rosati, J.; Artuso, S.; Manni, I.; Colussi, C.; Piaggio, G.; Martelli, F.; Valente, S.; Mai, A.; Capogrossi, M. C.; Farsetti, A.; Gaetano, C. A nitric oxide-dependent cross-talk between class I and III histone deacetylases accelerates skin repair J. Biol. Chem. 2013, 288 (16) 11004-12
-
(2013)
J. Biol. Chem.
, vol.288
, Issue.16
, pp. 11004-11012
-
-
Spallotta, F.1
Cencioni, C.2
Straino, S.3
Nanni, S.4
Rosati, J.5
Artuso, S.6
Manni, I.7
Colussi, C.8
Piaggio, G.9
Martelli, F.10
Valente, S.11
Mai, A.12
Capogrossi, M.C.13
Farsetti, A.14
Gaetano, C.15
-
16
-
-
30344477367
-
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
-
Minucci, S.; Pelicci, P. G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer Nat. Rev. Cancer 2006, 6 (1) 38-51
-
(2006)
Nat. Rev. Cancer
, vol.6
, Issue.1
, pp. 38-51
-
-
Minucci, S.1
Pelicci, P.G.2
-
17
-
-
34547897023
-
Histone deacetylases and cancer
-
Glozak, M. A.; Seto, E. Histone deacetylases and cancer Oncogene 2007, 26 (37) 5420-5432
-
(2007)
Oncogene
, vol.26
, Issue.37
, pp. 5420-5432
-
-
Glozak, M.A.1
Seto, E.2
-
18
-
-
41149089267
-
Histone deacetylase inhibitors: From bench to clinic
-
Paris, M.; Porcelloni, M.; Binaschi, M.; Fattori, D. Histone deacetylase inhibitors: from bench to clinic J. Med. Chem. 2008, 51 (6) 1505-1529
-
(2008)
J. Med. Chem.
, vol.51
, Issue.6
, pp. 1505-1529
-
-
Paris, M.1
Porcelloni, M.2
Binaschi, M.3
Fattori, D.4
-
19
-
-
77950860448
-
Inside HDAC with HDAC inhibitors
-
Bertrand, P. Inside HDAC with HDAC inhibitors Eur. J. Med. Chem. 2010, 45 (6) 2095-2116
-
(2010)
Eur. J. Med. Chem.
, vol.45
, Issue.6
, pp. 2095-2116
-
-
Bertrand, P.1
-
20
-
-
79251588033
-
Roles and targets of class i and IIa histone deacetylases in cardiac hypertrophy
-
Kee, H. J.; Kook, H. Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy J. Biomed. Biotechnol. 2011, 928326
-
(2011)
J. Biomed. Biotechnol.
, pp. 928326
-
-
Kee, H.J.1
Kook, H.2
-
21
-
-
23244443230
-
Nitric oxide in wound-healing
-
Isenberg, J. S.; Ridnour, L. A.; Espey, M. G.; Wink, D. A.; Roberts, D. D. Nitric oxide in wound-healing Microsurgery 2005, 25 (5) 442-51
-
(2005)
Microsurgery
, vol.25
, Issue.5
, pp. 442-451
-
-
Isenberg, J.S.1
Ridnour, L.A.2
Espey, M.G.3
Wink, D.A.4
Roberts, D.D.5
-
22
-
-
33645699825
-
Role of nitric oxide, nitroxidative and oxidative stress in wound healing
-
Soneja, A.; Drews, M.; Malinski, T. Role of nitric oxide, nitroxidative and oxidative stress in wound healing Pharmacol. Rep. 2005, 57, 108-19
-
(2005)
Pharmacol. Rep.
, vol.57
, pp. 108-119
-
-
Soneja, A.1
Drews, M.2
Malinski, T.3
-
23
-
-
0033551152
-
A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors
-
Saito, A.; Yamashita, T.; Mariko, Y.; Nosaka, Y.; Tsuchiya, K.; Ando, T.; Suzuki, T.; Tsuruo, T.; Nakanishi, O. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors Proc. Natl. Acad. Sci. U.S.A. 1999, 96 (8) 4592-4597
-
(1999)
Proc. Natl. Acad. Sci. U.S.A.
, vol.96
, Issue.8
, pp. 4592-4597
-
-
Saito, A.1
Yamashita, T.2
Mariko, Y.3
Nosaka, Y.4
Tsuchiya, K.5
Ando, T.6
Suzuki, T.7
Tsuruo, T.8
Nakanishi, O.9
-
24
-
-
0028604328
-
Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: Thiol-mediated nitric oxide release and biological evaluation
-
Medana, C.; Ermondi, G.; Fruttero, R.; Di Stilo, A.; Ferretti, C.; Gasco, A. Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation J. Med. Chem. 1994, 37 (25) 4412-4416
-
(1994)
J. Med. Chem.
, vol.37
, Issue.25
, pp. 4412-4416
-
-
Medana, C.1
Ermondi, G.2
Fruttero, R.3
Di Stilo, A.4
Ferretti, C.5
Gasco, A.6
-
25
-
-
84863649774
-
Chimerically designed HDAC and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGRF, HER2 and histone deacetylases
-
Beckers, T.; Mahboobi, S.; Sellmer, A.; Winkler, M.; Eichhorn, E.; Pongratz, H.; Maier, T.; Ciossek, T.; Baer, T.; Kelter, G.; Fiebig, H.-H.; Schmidt, M. Chimerically designed HDAC and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGRF, HER2 and histone deacetylases MedChemComm 2012, 3, 829-835
-
(2012)
MedChemComm
, vol.3
, pp. 829-835
-
-
Beckers, T.1
Mahboobi, S.2
Sellmer, A.3
Winkler, M.4
Eichhorn, E.5
Pongratz, H.6
Maier, T.7
Ciossek, T.8
Baer, T.9
Kelter, G.10
Fiebig, H.-H.11
Schmidt, M.12
-
26
-
-
58049221125
-
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment
-
Colussi, C.; Mozzetta, C.; Gurtner, A.; Illi, B.; Rosati, J.; Straino, S.; Ragone, G.; Pescatori, M.; Zaccagnini, G.; Antonini, A.; Minetti, G.; Martelli, F.; Piaggio, G.; Gallinari, P.; Steinkulher, C.; Clementi, E.; Dell'Aversana, C.; Altucci, L.; Mai, A.; Capogrossi, M. C.; Puri, P. L.; Gaetano, C. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment Proc. Natl. Acad. Sci. U.S.A. 2008, 105 (49) 19183-19187
-
(2008)
Proc. Natl. Acad. Sci. U.S.A.
, vol.105
, Issue.49
, pp. 19183-19187
-
-
Colussi, C.1
Mozzetta, C.2
Gurtner, A.3
Illi, B.4
Rosati, J.5
Straino, S.6
Ragone, G.7
Pescatori, M.8
Zaccagnini, G.9
Antonini, A.10
Minetti, G.11
Martelli, F.12
Piaggio, G.13
Gallinari, P.14
Steinkulher, C.15
Clementi, E.16
Dell'Aversana, C.17
Altucci, L.18
Mai, A.19
Capogrossi, M.C.20
Puri, P.L.21
Gaetano, C.22
more..
-
27
-
-
77950581254
-
Nitric oxide determines mesodermic differentiation of mouse embryonic stem cells by activating class IIa histone deacetylases: Potential therapeutic implications in a mouse model of hindlimb ischemia
-
Spallotta, F.; Rosati, J.; Straino, S.; Nanni, S.; Grasselli, A.; Ambrosino, V.; Rotili, D.; Valente, S.; Farsetti, A.; Mai, A.; Capogrossi, M. C.; Gaetano, C.; Illi, B. Nitric oxide determines mesodermic differentiation of mouse embryonic stem cells by activating class IIa histone deacetylases: potential therapeutic implications in a mouse model of hindlimb ischemia Stem Cells 2010, 28 (3) 431-442
-
(2010)
Stem Cells
, vol.28
, Issue.3
, pp. 431-442
-
-
Spallotta, F.1
Rosati, J.2
Straino, S.3
Nanni, S.4
Grasselli, A.5
Ambrosino, V.6
Rotili, D.7
Valente, S.8
Farsetti, A.9
Mai, A.10
Capogrossi, M.C.11
Gaetano, C.12
Illi, B.13
-
28
-
-
77950480186
-
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia
-
Liu, S.; Wu, L. C.; Pang, J.; Santhanam, R.; Schwind, S.; Wu, Y. Z.; Hickey, C. J.; Yu, J.; Becker, H.; Maharry, K.; Radmacher, M. D.; Li, C.; Whitman, S. P.; Mishra, A.; Stauffer, N.; Eiring, A M.; Briesewitz, R.; Baiocchi, R. A.; Chan, K. K.; Paschka, P.; Caligiuri, M. A.; Byrd, J. C.; Croce, C. M.; Bloomfield, C. D.; Perrotti, D.; Garzon, R.; Marcucci, G. Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia Cancer Cell 2010, 17 (4) 333-347
-
(2010)
Cancer Cell
, vol.17
, Issue.4
, pp. 333-347
-
-
Liu, S.1
Wu, L.C.2
Pang, J.3
Santhanam, R.4
Schwind, S.5
Wu, Y.Z.6
Hickey, C.J.7
Yu, J.8
Becker, H.9
Maharry, K.10
Radmacher, M.D.11
Li, C.12
Whitman, S.P.13
Mishra, A.14
Stauffer, N.15
Eiring, A.M.16
Briesewitz, R.17
Baiocchi, R.A.18
Chan, K.K.19
Paschka, P.20
Caligiuri, M.A.21
Byrd, J.C.22
Croce, C.M.23
Bloomfield, C.D.24
Perrotti, D.25
Garzon, R.26
Marcucci, G.27
more..
|